DNA damage in blood leucocytes of prostate cancer patients during therapy with 177Lu-PSMA.

Sarah SchumannHarry ScherthanConstantin LapaSebastian SerflingRazan MuhtadiMichael LassmannUta Eberlein

Published in: European journal of nuclear medicine and molecular imaging (2019)

The general pattern of the time- and dose-dependent induction and disappearance of RIF during 177Lu-PSMA therapy is similar to that of other radionuclide therapies.

Keyphrases

dna damage
pet ct
prostate cancer
pet imaging
oxidative stress
dna repair
stem cells
mesenchymal stem cells
benign prostatic hyperplasia